Syndax Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Clinical and Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/4/2026

1. KRG
2. SPY
3. ALAR
4. PRYMY
5. SKA-B
6. PBA
7. CCH:LN
8. META
9. CCHGY
10. PRY:IM

Go back to Syndax Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Clinical and Business Update

Syndax Pharmaceuticals (SNDX) PT Lowered to $20 at Citi; Reiterates Buy

August 11, 2017 8:56 AM EDT

Citi lowered its price target on Syndax Pharmaceuticals (NASDAQ: SNDX) to $20.00 (from $24.00) while maintaining a Buy rating. Citi... More